Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000513739 | SCV000610029 | uncertain significance | not provided | 2017-06-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001050909 | SCV001215038 | uncertain significance | Acromesomelic dysplasia 1, Maroteaux type; Tall stature-scoliosis-macrodactyly of the great toes syndrome | 2019-02-27 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with valine at codon 774 of the NPR2 protein (p.Ala774Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine. This variant is present in population databases (rs369154896, ExAC 0.02%). This variant has not been reported in the literature in individuals with NPR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 445544). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |